Summary Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were able to find a distinct difference between these two tumours. A total of 262 patients, 68 with FTC and 194 with OC, in stage I and II were included into this study. A univariate as well as a multivariate analysis for survival was performed, including factors such as age, histological type, grading and surgical and adjuvant treatment. A significantly poorer outcome (P = 0.0002) for FTC patients with a 5-year survival of 50.8% compared with 77.5% for OC patients was observed. This finding was persistent and independent of any investigated factor, in univariate as well as multivariate analyses. Therefore, we feel that a more aggressive therapeutic approach to the treatment of FTC even in early stages can be recommended. On the other hand, the retrospective character of our study has to be taken into account.
Primary carcinoma of the Fallopian tube (FTC) ranks among the rarest of gynaecological malignancies, with a prevalence reported to be 0.15-1.8% compared with 9.4-15.8% for epithelial ovarian cancer (OC) (Hanton et al., 1966; Dodson et al., 1970; Engeler et al., 1981; Bohme et al., 1992) . The average annual incidence of FTC is reported to be 2.9 per million women per year (Pfeiffer, 1989) .
Since both tumours have their origin in the Mullerian duct, OC and FTC are considered to be closely related (Frick, 1978) . Thus, FIGO staging (until September 1991) , surgical treatment and post-operative adjuvant therapy of FTC followed the lines established for OC (Hu et al., 1950; Behr et al., 1990; Morris et al., 1990; Pakisch et al., 1990) .
In most cases 'primary carcinoma of the Fallopian tube' is diagnosed intraoperatively or even as late as in the pathologist's post-operative histological examination; preoperatively, the tumour is mostly diagnosed as 'ovarian carcinoma' or 'malignant process in the adnexa' (Jones, 1965) . The present retrospective study analyses data over a 10-year period (First and Second Multicenter Studies on Ovarian Carcinoma in Austria and First Multicenter Study on Carcinoma of the Fallopian Tube in Austria), and aims at evaluating the prognostic characteristics of the two diseases.
Patients
During the period 1980 to 1990, patients operated on for epithelial ovarian carcinoma or primary carcinoma of the Fallopian tube in stage I and II were entered into this retrospective study.
Data on patients with Fallopian tube carcinoma were taken from a retrospective, multicentre analysis, including 23 gynaecological departments, and have been recently reported. (Rosen et al., 1993) .
Data for ovarian carcinoma were received from the University of Vienna (1st and 2nd Departments of Obstetrics and Gynecology) and were collected and analysed by the second author (P.S.) at the University of Vienna, Austria. They involved patients with OC who had been entered into two multicentre studies, from all over Austria. FTC as well as OC patients were followed until the control date, October 1992.
Patients with metastatic tumours, with a history of other malignancies and with borderline tumours were excluded from this study.
For the staging of Fallopian tube carcinoma a new FIGO classification, founded in Singapore, 1991, was used, whereas for ovarian carcinoma the FIGO classification was applied. A total of 68 patients with primary cancer of the Fallopian tube (FTC) in FIGO stage I and II were included into this study and were compared with 194 patients with ovarian carcinoma (OC) in the same stages (Table I ). The mean age of Fallopian tube patients was 60.4 years. The mean age of ovarian carcinoma patients was 56.1 years.
A total of 51 (73.6%) FTC patients were in stage I, compared with 162 (83.5%) OC patients. For stage II the figures were 17 (26.4%) and 32 (16.5%) for FTC and OC respectively (P = NS).
Histological evaluation and grading for FTC followed the criteria of Hu et al. (1950) . The histological evaluation of the epithelial ovarian cancer was by WHO criteria (Serov et al., 1973) . Histological grading was GI for well-differentiated and G3 for undifferentiated ovarian carcinomas and followed the criteria of Day et al. (1975) . Borderline tumours (GO) were excluded from this study.
The participating departments provided the study centre with histological specimens, which were evaluated by an independent pathologist (A.R.) for grading and histological type.
Total abdominal hysterectomy (TAH) with bilateral salpingo-oophorectomy (BSO) and additional infracolic resection of the omentum together with or without lymphadenectomy was achieved in 22 (32.4%) patients in the FTC group and 96 (49.5%) patients in the OC group (P= NS).
Post-operative radiotherapy was performed in 31 (45.6%) women with FTC and 65 (33.5%) women with OC using whole-abdominal irradiation with open-field techniques and total dosage of 45-55 Gy. The source of radiation was cobalt-60 in all patients and was applied within 6 weeks after surgery. (Kaplan & Meier, 1958; Cox, 1972; Mantel, 1986) .
Patients who died from any cause other than the primary disease were censored. Five patients with FTC died for reasons other than the primary disease compared with 12 patients with OC. Survival was regarded as the period from first treatment for OC or FTC until the time of death due to this disease or until the control date. Values of P <0.05 were considered to be statistically significant.
Cox proportional hazards regression (Cox, 1972) , as implemented by the program BMDP 2L (Dixon et al., 1990) , was used to analyse the role of prognostic factors in survival, both in a marginal, unadjusted and in a partial, adjusted sense. In this analysis the prognostic strength of a factor is described by estimates of the relative risk, and by the corresponding 95% confidence interval for the relative risk. Twosided P-values permit a judgement as to whether the relative risk differs significantly from 1. Wherever feasible, hazard plots were performed to assess the appropriateness of the proportional hazards assumption that underlies the Cox regression model. Log-likelihood ratio tests were used to determine the significance of factor combinations. Survival Survival data, describing the impact of various prognostic factors, are given in Table II . The results of the Cox analysis are shown in Table III . The fit of the model was checked by considering interaction and polynominal terms in a stepwise modelling process. Based on these analyses it can be concluded that a main-effects model suitably summarises the survival experiences of the patients. The results show that the presence of FTC was the most important adverse prognostic factor, the next being a higher degree of dedifferentiation (G2 + G3). Furthemore, age had a significant influence on survival (Table III) . (Gurney et al., 1990; Morris et al., 1990) . FTC spreads within the abdominal cavity in a manner similar to OC, first contiguously by invasion of adjacent organs (Erez et al., 1967; Benedet et al., 1977; Henderson et al., 1977) , second by lymphatic pathways, and third by haematogenous spread (Engstrom, 1957; Benedet et al., 1977; Yoonessi, 1979) .
Symptoms of FTC are predominantly non-specific (uterine bleeding, pelvic and/or abdominal pain, abnormal vaginal discharge, abdominal distension and ascites with or without intestinal symptoms, and pelvic mass). This might explain the low rate (2%) of preoperative diagnosis (Jones, 1965; Yoonessi, 1979) . FTC closely resembles OC with one striking difference, i.e. that in FTC abdominal pain is a frequent and early complaint (Roberts & Lifshitz, 1982) .
It seems that patients are able to seek medical attention earlier because FTC tends to present at an earlier stage than OC (Rosen et al., 1993) . Gurney et al. (1990) emphasises the same biological response of FTC and OC to therapy. We cannot share this view because of the evidently worse prognosis for FTC in stage I and II despite the same treatment and the earlier diagnosis of FTC (Gurney et al., 1990; Rosen et al., 1993) . (Figure 1) influence independent of any applied treatment modality (Tables II, III and Figure 1 ).
Unlike OC, there are no specific therapeutic guidelines available for FTC. The literature offers only retrospective studies and reports on series too small to allow definitive conclusions (Phelps & Chapman, 1974; Morris et al., 1990; Pakisch et al., 1990; Barakat et al., 1991) .
Our study too, though based on a homogeneous patient series of 68 FTC cases (Rosen et al., 1993) , is retrospective and cannot provide conclusive guidelines for therapy. Yet, we feel that some recommendations can be given. Postoperative treatment of FTC, either chemo-or radiotherapy, which hitherto followed the example of OC, should be actively pursued, and we think that the decision to apply adjuvant treatment in FTC patients should be made even in earlier stages.
Patients with FIGO stage IA, in particular, should receive adjuvant treatment as well, irrespective of their histological grading, and in contrast to OC, so that a benefit from early diagnosis might be achieved. However, to determine definitive guidelines for treatment of FTC multicentric, prospective (probably international) trials will be mandatory.
